Ra Capital Management, L.P. Dyne Therapeutics, Inc. Put Options Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
202Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$234 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$229 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$216 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$187 Million3.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$138 Million0.0% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.51B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...